Research Article

QSAR Study of Anthra[1,9-cd]pyrazol-6(2H)-one Derivatives as Potential Anticancer Agents Using Statistical Methods

Table 3

Comparison between activities observed and predicted of statistically significant models obtained by 2D models training set.

Comp.PIC50Pred. (PIC50) RLMResidu.CVComp.PIC50Pred. (PIC50) RNLMResidu.Comp.PIC50Pred. (PIC50) PLSResidu.Comp.PIC50Y-rd

11,2581,1830,0751,3611,2581,1920,06611,2581,2420,016201,491,39
21,2511,318−0,0671,3231,4911,3630,12821,2511,390−0,13921,251,34
41,0001,017−0,0180,9841,0001,089−0,08931,4911,3050,186411,19
61,1091,215−0,1061,1151,3401,1750,16551,3401,2280,112301,511,38
71,2001,247−0,0471,2261,1091,220−0,11161,1091,268−0,16071,21,26
91,1601,398−0,2381,3181,3021,352−0,05071,2001,313−0,113101,391,4
101,3861,3180,0681,3991,1601,298−0,13781,3021,350−0,04861,111,11
111,5561,3950,1611,23101,3861,478−0,092101,3861,390−0,005120,951
120,9461,173−0,2271120,9461,116−0,170111,5561,4850,072311,51,48
131,5051,4110,0941,41131,5051,4220,083141,5311,3840,147251,271,24
141,5311,3790,1531,37141,5311,3870,145150,9260,8950,031160,740,89
160,7400,6600,0791150,9260,8580,068171,1371,176−0,039181,461,47
181,4551,503−0,0481,44160,7400,805−0,066191,4841,4760,008191,481,47
191,4841,4220,0621,43181,4551,557−0,102201,4861,488−0,002111,561,28
201,4861,4800,0051,44191,4841,4840,001211,4891,4570,031261,521,46
211,4891,4750,0131,46201,4861,508−0,023221,4901,3680,122221,491,43
221,4901,3410,1491,43211,4891,496−0,007231,3461,390−0,044241,251,42
241,2541,387−0,1331,41221,4901,3450,144241,2541,394−0,140291,321,33
251,2721,289−0,0171,3231,3461,3050,040251,2721,338−0,067131,511,41
261,5191,4040,1151,47261,5191,4410,077261,5191,4370,08111,261,25
281,4931,4860,0061,43271,4871,4320,055271,4871,505−0,01791,161,29
291,3241,387−0,0631,31281,4931,518−0,025281,4931,4880,004141,531,38
301,5051,514−0,0091,43301,5051,615−0,110291,3241,374−0,050211,491,3
311,5041,512−0,0081,48321,4971,4880,009311,5041,4900,014281,491,45